News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
03-Jun-2015 - Genticel announced positive preclinical in vivo proof of concept results of GTL002, its multivalent HPV therapeutic vaccine candidate based on the Company’s versatile Vaxiclase platform.No treatment options are available for women infected with oncogenic HPV types but who have not yet developed ...
02-Jun-2015 - DNA Therapeutics, a private biopharmaceutical company developing DT01, a first-in-class clinical pan DNA repair inhibitor to treat tumors resistant to conventional treatments, will today present the results of the first-in-man phase 1/2a trial of DT01 in combination with radiation therapy in ...
07-May-2015 - Novasep announces two new appointments to its executive committee (COMEX). Pierre-Louis Mikus joins as chief legal officer. Bertrand Waymel is promoted to group human resources director. Both appointees will be based at Novasep’s management center in Lyon Gerland, a vibrant biotech hub.The ...
07-May-2015 - Kallistem, which develops cell culture technologies in reproductive biology, announces a world first: human spermatogenesis in vitro. At the end of 2014 the company was able to produce fully formed human spermatozoa in the laboratory setting, using patient testicular biopsies containing only ...
04-May-2015 - Biocitech announced the 2014 results achieved by its residents. Biocitech residents submitted encouraging results for 2014, with growth in many areas. The overall revenue for the complex’s residents grew by 21%, from €51.3 million ($55.5 million) in 2013 to €62 million ($67 million) in 2014. Some ...
10-Apr-2015 - Metabolium announces the appointment of Dr. Khadidja Romari as chief operating officer and chief scientific director.Before joining the company, Romari spent several months as scientific advisor to Dominique Duvauchelle, CEO of Metabolium, to gain an understanding of the technologies developed by ...
01-Apr-2015 - Vaxon Biotech announces the appointment of company founder Dr. Konstantinos (Kostas) Kosmatopoulos, MD, PhD, as CEO. Kostas moves from his current role as chief scientific officer. He will use his experience as a medical oncologist and immunologist to lead the company forward during a very ...
05-Mar-2015 - Alizé Pharma announced the launch of a Phase II clinical trial of AZP-531, its unacylated ghrelin analog, in patients with Prader-Willi syndrome.The trial is a randomized, double blind and placebo controlled study. It aims to evaluate the safety and effects of a two-week treatment with AZP-531 ...
26-Feb-2015 - Prexton Therapeutics announced the closing of a Series A financing of €8.7 million ($10 million) co-led by Sunstone Capital and Ysios Capital. MS Ventures, the company's founding investor, will also participate. This first funding will help Prexton Therapeutics to develop novel small molecules ...
27-Jan-2015 - Promethera Biosciences announces the resignation of Eric Halioua from his post as CEO of Promethera and all other functions within the company. He has decided to leave in order to concentrate on other projects.As CEO of the company since it was founded in 2009, Eric Halioua was the driving force ...
© 1997-2024 LUMITOS AG, All rights reserved